期刊
OBESITY REVIEWS
卷 22, 期 4, 页码 -出版社
WILEY
DOI: 10.1111/obr.13156
关键词
inflammation; lncRNAs; long noncoding RNAs; obesity
资金
- Versus Arthritis [21812]
Obesity is associated with chronic low-grade inflammation and long noncoding RNAs have been identified as key regulators of inflammatory pathways. Some lncRNAs are differentially expressed in obesity and related conditions like insulin resistance, type 2 diabetes, sarcopenia, osteoarthritis, and rheumatoid arthritis. Understanding the role of lncRNAs in mediating obesity-associated inflammation may lead to new therapeutic targets.
Obesity is associated with chronic low-grade inflammation that affects the phenotype of multiple tissues and therefore is implicated in the development and progression of several age-related chronic inflammatory disorders. Importantly, a new family of noncoding RNAs, termed long noncoding RNAs (lncRNAs), have been identified as key regulators of inflammatory signalling pathways that can mediate both pretranscriptional and posttranscriptional gene regulation. Furthermore, several lncRNAs have been identified, which are differentially expressed in multiple tissue types in individuals who are obese or in preclinical models of obesity. In this review, we examine the evidence for the role of several of the most well-studied lncRNAs in the regulation of inflammatory pathways associated with obesity. We highlight the evidence for their differential expression in the obese state and in age-related conditions including insulin resistance, type 2 diabetes (T2D), sarcopenia, osteoarthritis and rheumatoid arthritis, where obesity plays a significant role. Determining the expression and functional role of lncRNAs in mediating obesity-associated chronic inflammation will advance our understanding of the epigenetic regulatory pathways that underlie age-related inflammatory diseases and may also ultimately identify new targets for therapeutic intervention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据